Infectious Diseases News and Research

RSS

Broadly neutralizing antibodies offer a new approach to treating HIV infection

A new generation of broadly neutralizing antibodies provides a novel approach to treating HIV infection.

28 Sep 2018

Study aims to investigate antimicrobial resistance of uropathogenic E. coli from elderly patients

Urinary Tract Infection is a common cause of morbidity and mortality in older adults. Escherichia coli is one of the bacterial agents with higher prevalence in community-acquired and health care associated urinary infections in elderly patients.

27 Sep 2018

Fina Biosolutions receives patent for expression and purification of the conjugate vaccine protein

Fina Biosolutions announces that the United States Patent and Trademark Office has issued a patent for expression and purification of the conjugate vaccine protein CRM197 in E. coli.

27 Sep 2018

GARDP partners with Novartis to accelerate development of generic antibiotic treatments for children

The Global Antibiotic Research & Development Partnership and Novartis are joining forces to accelerate the development and availability of generic antibiotic treatments for children in low- and middle-income countries.

27 Sep 2018

Auto-FMT found to be safe, effective way to replenish beneficial gut bacteria in cancer patients

Researchers at Memorial Sloan Kettering Cancer Center have shown that autologous fecal microbiota transplantation (auto-FMT) is a safe and effective way to help replenish beneficial gut bacteria in cancer patients who require intense antibiotics during allogenic hematopoietic stem cell transplantation.

27 Sep 2018

Antibiotic resistance in cystic fibrosis linked to decreased microbial diversity and pulmonary function

A defective gene causes thick, sticky mucus to build up in the lungs of patients with cystic fibrosis. There, it traps bacteria, causing patients to develop frequent lung infections that progressively damage these vital organs and impair patients' ability to breathe.

27 Sep 2018

NIAID releases strategic plan to expand knowledge of TB by using modern tools

Tuberculosis (TB) is the leading infectious cause of death worldwide, killing roughly 1.6 million people in 2017. In the past 200 years, TB claimed the lives of more than one billion people--more deaths than from malaria, influenza, smallpox, HIV/AIDS, cholera and plague combined.

27 Sep 2018

TGen-UNM consortium awarded NIH grant to discover new treatments for diabetic blindness

Diabetes is an increasing global epidemic that is expected to grow by more than 50 percent in the next two decades, leaving more than half a billion patients worldwide exposed to potentially life-altering medical complications, including pain and numbness in the feet, lost limbs, life-threatening disorders of the heart, liver and kidneys -- and even blindness.

26 Sep 2018

Researchers aim to develop vaccine for 'traveler's diarrhea'

Every year, millions of people have vacations and business trips ruined when they succumb to "traveler's diarrhea" during their journeys. A major cause of traveler's diarrhea is bacteria called Enterotoxigenic E. coli, or ETEC.

26 Sep 2018

UNC researchers receive NIH award to study maternal-fetal transmission of Zika virus

Researchers at the University of North Carolina at Chapel Hill and collaborators in Nicaragua have been given a five-year, $2.7 million R01 award from the U.S. National Institutes of Health to better understand the epidemiology of Zika virus in pregnancy and the impact the virus has on infant neurodevelopment.

26 Sep 2018

UC Davis researchers take critical step in developing more effective Salmonella vaccine

UC Davis researchers announce in the Proceedings of the National Academy of Sciences this week a breakthrough in understanding which cells afford optimal protection against Salmonella infection--a critical step in developing a more effective and safe vaccine against a bacterium that annually kills an estimated one million people worldwide.

25 Sep 2018

October 1918 marks the centenary of Spanish Flu that claimed more lives than World War I

JUST as the cataclysmic conflict of the Great War was in its death throes, a new killer emerged that would, on a global scale, be even more lethal - the Spanish Flu pandemic, which was at its most virulent in October and November 1918.

24 Sep 2018

Australia's HIV diagnoses hit seven year low

According to latest numbers from the Kirby Institute at the University of New South Wales (UNSW), the rates of HIV are on the rise among heterosexuals in Australia.

23 Sep 2018

Scientist intends to fight pathogenic bacteria with viruses

Dr. Li Deng of Helmholtz Zentrum München has been awarded a Starting Grant of the European Research Council. The scientist intends to tackle antimicrobial resistance by fighting bacteria with their natural enemies - the viruses. The grant is endowed with nearly 1.5 million euros for five years.

21 Sep 2018

Research finds drop in number of measles cases in the EU/EEA since March 2018

During the month of July, a total of 758 cases of measles were reported across seventeen countries in the EU/EEA, which is a decrease from the 1054 cases reported during the month of June.

21 Sep 2018

Study reveals surprising gaps in some HIV medical providers' knowledge of ACA

A new study has revealed surprising gaps in some HIV medical providers' knowledge of the Affordable Care Act, with more than a quarter of providers surveyed unable to say whether their state had expanded Medicaid.

21 Sep 2018

Study highlights need to remain vigilant in maintaining key infection control processes

Healthcare-associated infections can be reduced by up to 55 percent by systematically implementing evidence-based infection prevention and control strategies, according to a review of 144 studies published today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.

21 Sep 2018

NIH launches clinical trial to test infusions of combination antibodies in people with HIV

A clinical trial testing infusions of combination antibodies in people living with HIV has begun at the National Institutes of Health.

20 Sep 2018

Scientists achieve breakthrough in accelerated diagnosis of multi-resistant hospital pathogens

A team of researchers at the University of Cologne's Faculty of Medicine and the German Center for Infection Research has achieved a scientific breakthrough in the accelerated diagnosis of multi-resistant hospital pathogens.

20 Sep 2018

Emergex signs MoU with Brazil’s Fiocruz for development of viral vaccines

Emergex Vaccines Holding Limited, a biotechnology company pioneering a new approach to synthetic vaccine development in the field of infectious diseases, today announces that it has signed a Memorandum of Understanding with Brazil-based Oswaldo Cruz Foundation 'Fiocruz' for the development of viral vaccines.

20 Sep 2018

Infectious Diseases News and Research

Broadly neutralizing antibodies offer a new approach to treating HIV infection

Study aims to investigate antimicrobial resistance of uropathogenic E. coli from elderly patients

Fina Biosolutions receives patent for expression and purification of the conjugate vaccine protein

GARDP partners with Novartis to accelerate development of generic antibiotic treatments for children

Auto-FMT found to be safe, effective way to replenish beneficial gut bacteria in cancer patients

Antibiotic resistance in cystic fibrosis linked to decreased microbial diversity and pulmonary function

NIAID releases strategic plan to expand knowledge of TB by using modern tools

TGen-UNM consortium awarded NIH grant to discover new treatments for diabetic blindness

Researchers aim to develop vaccine for 'traveler's diarrhea'

UNC researchers receive NIH award to study maternal-fetal transmission of Zika virus

UC Davis researchers take critical step in developing more effective Salmonella vaccine

October 1918 marks the centenary of Spanish Flu that claimed more lives than World War I

Australia's HIV diagnoses hit seven year low

Scientist intends to fight pathogenic bacteria with viruses

Research finds drop in number of measles cases in the EU/EEA since March 2018

Study reveals surprising gaps in some HIV medical providers' knowledge of ACA

Study highlights need to remain vigilant in maintaining key infection control processes

NIH launches clinical trial to test infusions of combination antibodies in people with HIV

Scientists achieve breakthrough in accelerated diagnosis of multi-resistant hospital pathogens

Emergex signs MoU with Brazil’s Fiocruz for development of viral vaccines

eBook: Advancing infectious disease vaccine development eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News